Mirtazapine Tablet, Film Coated
Product Images NDC 71610-846

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71610-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0846 15)

Label for Mirtazapine USP 30 mg film-coated tablets, containing 15 tablets. The label includes storage instructions, manufacturer information (Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN), and packaging guidance. The NDC number 71610-846-15 is also present on the label.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Mirtazapine Tablets Usp 1)

Chemical structure of the active ingredient Mirtazapine, showing its fused ring system with nitrogen atoms and a methyl-substituted nitrogen group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.